Solvonis Therapeutic reports vital patent milestone achieved for SVN 114
Solvonis Therapeutics PLC said a vital patent milestone has been achieved for SVN 114, according to an RNS announcement dated 03 September 2026.
RNS Number: 1771T Solvonis Therapeutics PLC 03 September 2026 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.
UPON THE PUBLICATION…